Dansk English

Kalundborg Bioenergi

In co-operation with Ørsted (former DONG) Bigadan is constructing a full-scale biogas plant which will handle waste products from the insulin and enzyme production at Novo Nordisk and Novozymes. Construction will commence in the spring of 2017, and the biogas plant will be commissioned in the spring of 2018 producing what is equivalent to the annual natural gas consumption of 5.000 households.

Both Bigadan and Ørsted will own the biogas plant but Bigadan will be in charge of operating it.

Plant facts

  • Location Kalundborg
  • Supplier Bigadan A/S
  • Client Kalundborg Bioenergi A/S
  • Scope of delivery Turnkey biogas plant incl gas upgrading plant
  • Year of delivery 2018
  • Capacity 300.000 t/year
  • Biomass Waste products from insulin and enzyme production
  • Biogas capacity 8 million m³/a
  • Biogas utilization Gas upgrading to natural gas and injection into natural gas grid